Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Melanie Wain Kier"'
Autor:
Julia Blanter, Michael Werner, Melanie Wain Kier, Olivia Hapanowicz, Muhieddine Itani, Maham Ahmad, Mandy DeMerchant, Joseph Paul Eder, Matt D. Galsky, Ashley Hammad, Paula King, Michael Lachowicz, Natalie Lucas, Thomas Urban Marron, Gary Shelton, Kathy Wu, Suzanne Xu, Patricia LoRusso, Erin Wysong Hofstatter, Deborah Blythe Doroshow
Publikováno v:
Journal of Clinical Oncology. 40:267-267
267 Background: Financial toxicity (FT) adversely influences patient quality of life and is a barrier to clinical trial enrollment. Early phase clinical trials (EPTs) primarily recruit patients with advanced malignancies who have received all standar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caa5036ccaf65da7e65666f299d57b88
https://doi.org/10.1200/jco.2022.40.28_suppl.267
https://doi.org/10.1200/jco.2022.40.28_suppl.267
Autor:
Fauzia Riaz, Huili Zhu, Wei Cheng, Samantha Brongiel, Elena Baldwin, Melanie Wain Kier, Jacob Zaemes, Caleb Hearn, Osama Abdelghany, Ravi Bharat Parikh, Joshua E. Reuss, Elizabeth Horn Prsic, Deborah Blythe Doroshow
Publikováno v:
Journal of Clinical Oncology. 40:300-300
300 Background: Immune checkpoint inhibitors (ICIs) have revolutionized the care of patients (pts) with cancer. However, median time to response is 2-6 months and many pts derive no benefit from ICIs. Pts are often admitted to the hospital with compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a645299846e70f375a676d5301bff9b
https://doi.org/10.1200/jco.2022.40.28_suppl.300
https://doi.org/10.1200/jco.2022.40.28_suppl.300
Autor:
Melanie Wain Kier, Sara Lubetsky, Gabrielle Schiller, Albert L. Siu, Katherine A. Ornstein, Cardinale B. Smith
Publikováno v:
Journal of Clinical Oncology. 40:257-257
257 Background: Hospitalization at Home (HaH) is an emerging clinical model that delivers the essential elements of acute hospital-level care in the home and has demonstrated efficacy largely for inpatient medical conditions. Few programs have implem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28b91b3e306d72c292ab69841d73d527
https://doi.org/10.1200/jco.2022.40.28_suppl.257
https://doi.org/10.1200/jco.2022.40.28_suppl.257
Autor:
Rima Patel, Malin Hovstadius, Melanie Wain Kier, Erin Moshier, Brittney Shulman Zimmerman, Krystal Pauline Cascetta, Shabnam Jaffer, Joseph A. Sparano, Amy Tiersten
Publikováno v:
Journal of Clinical Oncology. 40:553-553
553 Background: The 21-gene RS (Oncotype DX) provides prognostic information for distant recurrence risk and is predictive of adjuvant chemotherapy benefit in hormone receptor (HR)-positive, HER-2 negative EBC. Ki67 protein expression is a proliferat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6056d10b558192da265647658d67ce16
https://doi.org/10.1200/jco.2022.40.16_suppl.553
https://doi.org/10.1200/jco.2022.40.16_suppl.553
Autor:
Melanie Wain Kier, Sara Lubetsky, Gabrielle Schiller, Albert L. Siu, Katherine A. Ornstein, Cardinale B. Smith
Publikováno v:
Journal of Clinical Oncology. 40:1523-1523
1523 Background: Hospitalization at Home (HaH) is an emerging clinical model that delivers the essential elements of acute hospital-level care in the home and has demonstrated efficacy largely for inpatient medical conditions. Few programs have imple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1d65bf110b8316a6f9e4812822a96ff
https://doi.org/10.1200/jco.2022.40.16_suppl.1523
https://doi.org/10.1200/jco.2022.40.16_suppl.1523
Autor:
Melanie Wain Kier, Zhiqiang Li, Nicole Casasanta, Rima Patel, Parul Agarwal, Brittney Shulman Zimmerman, Yunchen Yang, Marc Y Fink, Xiang Zhou, Scott Newman, Rong Chen, Eric Schadt, William K. Oh, Amy Tiersten
Publikováno v:
Journal of Clinical Oncology. 40:523-523
523 Background: Socioeconomic disparities impact breast cancer survival with significantly higher mortality among women of lower socioeconomic status. Little is known about how disparities affect patients with early-stage hormone receptor positive (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a3538ae6140911aab98e9072ad91581
https://doi.org/10.1200/jco.2022.40.16_suppl.523
https://doi.org/10.1200/jco.2022.40.16_suppl.523